Effectiveness of Double-layer Compression Therapy in the Healing of Chronic Venous Ulcers in Primary Health Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

93 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effectiveness of a multilayer compression bandage (two layers), compared with the crepe bandage, on healing of venous leg ulcers, in patients attended in nursing Primary Care Health Centres, at 12 weeks follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Compressive Therapies on the Healing of Venous Ulcers

NCT04703569

Venous Ulcers

COMPLETED NA

Community RCT of the Effectiveness of Two Compression Bandaging Technologies

NCT00202267

Venous Ulcer

COMPLETED PHASE2

Compression Device Versus 4-layer Compression System

NCT00821431

Leg Ulcers

COMPLETED PHASE2

Randomized Controlled 8-week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers

NCT00301496

Venous Ulcer

COMPLETED NA

Comparison of the Effectiveness of Two Medical Compression Bandage Application Techniques by Measuring Interface Pressures Depending on Whether or Not the Heel is Included in Patients With Open Venous Ulcers

NCT04046120

Venous Ulcer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study also compares the effectiveness of the multilayer and the crepe bandage, on healing of venous leg ulcers measured by the Resvech 2.0 scale and evaluates improvement in quality of life, measured by the Charing Cross Venous Ulcer Questionnaire (CCVUQ-e) and analyze the sociodemographic, clinical, and treatment factors associated with complete healing of venous ulcers.

Design: Multicentre, controlled, parallel group, randomized clinical trial, with blind evaluation of the response variable.

Setting: Primary Care Health Centres (Madrid). Subjects: Patients with venous leg ulcers, treated by nurses at the participating centres.

Intervention: Experimental group: multilayer compression bandage (two layers). Control group: crepe bandage.

Sample size: 216 patients (108 in each group) Variables:Main: Complete healing after 12 weeks follow-up. Secondary: Degree of healing (Resvech 2.0). Quality of life (CCVUQ-e). Adverse reactions. Related to the healing process: comorbidities, topical and systematic treatments, exercise, BMI. Prognostic factors: location, number and duration of ulcer. Sociodemographic factors Data analysis: By intention to treat. Comparative analysis of the two groups (chi-squared or t-test). Effectiveness analysis sing Kaplan-Meier, log rank test and cox regression analysis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Ulcers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Two-layer compression bandage

Two multilayer compression bandage: Usual clinical practice in venous ulcer in wound care in assessing, cleaning, desinfection, debridement and topical treatment.Measure the ankle circumference and choose the correct kit accordingly (ankle size 18-25cm or 25-32cm). Apply one to seven days

Group Type EXPERIMENTAL

Two multilayer compression bandage

Intervention Type DEVICE

Usual clinical practice in venous ulcer in wound care in assessing, cleaning, desinfection, debridement and topical treatment.

Compression therapy: a multilayer compression bandage with two layers, suitable for the treatment of venous leg ulcers and to reduce edema chronic venous be used. Apply one two seven days

crepe bandage

Crepe bandage: Usual clinical practice in venous ulcer in wound care. crepe bandage apply one to seven days

Group Type ACTIVE_COMPARATOR

Crepe bandage

Intervention Type DEVICE

Crepe bandage: Usual clinical practice in venous ulcer in wound care. crepe bandage apply one to seven days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Two multilayer compression bandage

Usual clinical practice in venous ulcer in wound care in assessing, cleaning, desinfection, debridement and topical treatment.

Compression therapy: a multilayer compression bandage with two layers, suitable for the treatment of venous leg ulcers and to reduce edema chronic venous be used. Apply one two seven days

Intervention Type DEVICE

Crepe bandage

Crepe bandage: Usual clinical practice in venous ulcer in wound care. crepe bandage apply one to seven days

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

K2 Urgo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People With a diagnosis of chronic venous ulcer over six weeks duration.
* Presence of a larger Ankle Arm index (ABI) of 0.8 and less than 1.3.
* People Able to follow the trial own demands, able to understand the questionnaires, with no intention of moving and localizable for the duration of the study.
* That give written informed consent to participate

Exclusion Criteria

* Patients diagnosed with poorly controlled diabetes mellitus (last HbA1c greater than 7).
* In Antineoplastic therapy.
* Decompensated heart -insufficience .
* Dermatitis acute phase, at the time of the study.
* Rheumatoid-arthritis.
* Thrombosis Venosa (DVT) in acute phase.
* Patients with mixed ulcers
* Patients who participate simultaneously in another clinical trial.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No